Indacaterol/glycopyrronium versus salmeterol/fluticasone in the prevention of clinically important deterioration in COPD: results from the FLAME study. (2018)
Attributed to:
Mechanisms, impact and therapeutic targeting of bacterial colonisation in COPD
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1186/s12931-018-0830-z
PubMed Identifier: 29925383
Publication URI: http://europepmc.org/abstract/MED/29925383
Type: Journal Article/Review
Volume: 19
Parent Publication: Respiratory research
Issue: 1
ISSN: 1465-9921